Jenburkt Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE354A01013
NSEID:
BSEID: 524731
View on BSE

INR

1,101.45

12.05 (1.11%)

BSENSE

Jul 17, 03:30 PM

BSE+NSE Vol: 428

{
  "main_header": {
    "sid": 134395,
    "name": "Jenburkt Pharma",
    "stock_name": "Jenburkt Pharma",
    "full_name": "Jenburkt Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/jenburkt-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,101.45",
    "chg": 12.05,
    "chgp": "1.11%",
    "dir": 1,
    "prev_price": "1,089.40",
    "mcapval": "485.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524731,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE354A01013",
    "curr_date": "Jul 17, 03:30 PM",
    "curr_time": "20:02 PM",
    "last_traded_at": "Jul 17, 03:30 PM IST",
    "bse_nse_vol": "428 ",
    "exc_status": "Active",
    "traded_date": "Jul 17, 2026",
    "traded_date_str": "2026 07 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jenburkt-pharma-134395-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jenburkt Pharmaceuticals Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4103769",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JenburktPharmac_mojoScore_4103769.png",
        "date": "2026-07-15 10:10:06",
        "description": "Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 15 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-ltd-is-rated-hold-4088240",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JenburktPharmac_mojoScore_4088240.png",
        "date": "2026-07-04 10:10:47",
        "description": "Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Jenburkt Pharmaceuticals Declines 1.13%: Valuation Shift and Mixed Signals Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-declines-113-valuation-shift-and-mixed-signals-shape-the-week-4076103",
        "imagepath": "",
        "date": "2026-06-28 16:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>22 Jun:</strong> Valuation shift to fair grade announced amid sector comparisons</p>\n                    <p><strong>23 Jun:</strong> Downgrade to Hold rating by MarketsMOJO reflecting mixed signals</p>\n                    <p><strong>24 Jun:</strong> Minor price gains amid stabilising technical indicators</p>\n                    <p><strong>25 Jun:</strong> Slight dip closes the week at Rs.1,128.00 (-0.01%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,140.90</div>\n                    </div>\n           ..."
      },
      {
        "title": "Jenburkt Pharmaceuticals Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4067981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_mojoScore_4067981.png",
        "date": "2026-06-23 08:02:09",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 22 June 2026. This adjustment reflects a nuanced shift across four key parameters: quality, valuation, financial trend, and technical indicators. While the company demonstrates solid fundamentals and operational efficiency, evolving market dynamics and technical signals have prompted a more cautious stance."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-valuation-shift-enhances-price-attractiveness-amid-sector-comparisons-4066460",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_valuationdot_4066460.png",
        "date": "2026-06-22 08:00:07",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a significant valuation reassessment, shifting from an expensive to a fair valuation grade. This change, accompanied by a Mojo Score upgrade to 72.0 and a Buy rating, highlights a notable improvement in price attractiveness relative to its historical and peer benchmarks."
      },
      {
        "title": "Jenburkt Pharmaceuticals Declines 3.92% Amid Mixed Technical Signals and Upgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-declines-392-amid-mixed-technical-signals-and-upgrade-4066347",
        "imagepath": "",
        "date": "2026-06-21 16:00:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> Stock opens at Rs.1,174.55, down 1.09% amid broad market gains</p>\n                    <p><strong>16 Jun:</strong> Rating upgraded to Buy by MarketsMOJO on improved technicals and financials</p>\n                    <p><strong>18 Jun:</strong> Stock rallies 2.56% to Rs.1,178.30 on bullish technical momentum</p>\n                    <p><strong>19 Jun:</strong> Sharp decline of 3.17% to Rs.1,140.90 amid mixed technical signals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,187.45</div></div>\n                    <div class=\"stat-item\"><div..."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Signal Cautious Optimism",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-signal-cautious-optimism-4062536",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_technicaldot_4062536.png",
        "date": "2026-06-19 08:00:09",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Recent price action and technical indicators such as MACD, RSI, and moving averages reveal a complex but cautiously optimistic outlook for investors as the stock trades near ₹1,178.30, up 2.56% on the day."
      },
      {
        "title": "Jenburkt Pharmaceuticals Upgraded to Buy on Improved Technicals and Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-upgraded-to-buy-on-improved-technicals-and-financial-metrics-4058071",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_mojoScore_4058071.png",
        "date": "2026-06-17 08:01:31",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 16 June 2026. This upgrade reflects a combination of improved technical indicators, solid financial performance, and a favourable valuation outlook, signalling renewed investor confidence despite recent price volatility."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4057950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_technicaldot_4057950.png",
        "date": "2026-06-17 08:00:22",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its technical momentum, upgrading its MarketsMOJO grade from Hold to Buy as of 16 June 2026. Despite a modest day decline of 1.50%, the stock’s technical indicators reveal a strengthening bullish trend, signalling potential opportunities for investors amid mixed broader market conditions."
      }
    ],
    "total": 526,
    "sid": "134395",
    "stock_news_url": "https://www.marketsmojo.com/news/jenburkt-pharmaceuticals-134395"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
      "datetime": "13-Jul-2026",
      "details": "Intimation of shifting of Registered Office of the Company within the local limits of city of Mumbai.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "10-Jul-2026",
      "details": "Certificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended on 30th June 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "18-Jun-2026",
      "details": "Intimation of Closure of Trading Window of Jenburkt Pharmaceuticals Limited as per SEBI(Prohibition of Insider Trading) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jenburkt Pharmaceuticals Ltd. has declared <strong>180%</strong> dividend, ex-date: 11 Jul 25",
          "dt": "2025-07-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jenburkt Pharmaceuticals Ltd. is Rated Hold by MarketsMOJO

2026-07-15 10:10:06

Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 15 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jenburkt Pharmaceuticals Ltd. is Rated Hold

2026-07-04 10:10:47

Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Jenburkt Pharmaceuticals Declines 1.13%: Valuation Shift and Mixed Signals Shape the Week

2026-06-28 16:00:05

Key Events This Week

22 Jun: Valuation shift to fair grade announced amid sector comparisons

23 Jun: Downgrade to Hold rating by MarketsMOJO reflecting mixed signals

24 Jun: Minor price gains amid stabilising technical indicators

25 Jun: Slight dip closes the week at Rs.1,128.00 (-0.01%)

Week Open

Rs.1,140.90

...

Read full news article

Jenburkt Pharmaceuticals Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-06-23 08:02:09

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 22 June 2026. This adjustment reflects a nuanced shift across four key parameters: quality, valuation, financial trend, and technical indicators. While the company demonstrates solid fundamentals and operational efficiency, evolving market dynamics and technical signals have prompted a more cautious stance.

Read full news article

Jenburkt Pharmaceuticals Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Comparisons

2026-06-22 08:00:07

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a significant valuation reassessment, shifting from an expensive to a fair valuation grade. This change, accompanied by a Mojo Score upgrade to 72.0 and a Buy rating, highlights a notable improvement in price attractiveness relative to its historical and peer benchmarks.

Read full news article

Jenburkt Pharmaceuticals Declines 3.92% Amid Mixed Technical Signals and Upgrade

2026-06-21 16:00:51

Key Events This Week

15 Jun: Stock opens at Rs.1,174.55, down 1.09% amid broad market gains

16 Jun: Rating upgraded to Buy by MarketsMOJO on improved technicals and financials

18 Jun: Stock rallies 2.56% to Rs.1,178.30 on bullish technical momentum

19 Jun: Sharp decline of 3.17% to Rs.1,140.90 amid mixed technical signals

Week Open

Rs.1,187.45

Read full news article

Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Signal Cautious Optimism

2026-06-19 08:00:09

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Recent price action and technical indicators such as MACD, RSI, and moving averages reveal a complex but cautiously optimistic outlook for investors as the stock trades near ₹1,178.30, up 2.56% on the day.

Read full news article

Jenburkt Pharmaceuticals Upgraded to Buy on Improved Technicals and Financial Metrics

2026-06-17 08:01:31

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 16 June 2026. This upgrade reflects a combination of improved technical indicators, solid financial performance, and a favourable valuation outlook, signalling renewed investor confidence despite recent price volatility.

Read full news article

Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Signal Bullish Outlook

2026-06-17 08:00:22

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its technical momentum, upgrading its MarketsMOJO grade from Hold to Buy as of 16 June 2026. Despite a modest day decline of 1.50%, the stock’s technical indicators reveal a strengthening bullish trend, signalling potential opportunities for investors amid mixed broader market conditions.